FY2025 EPS Estimates for Organigram Cut by Atb Cap Markets

Organigram Holdings Inc. (TSE:OGIFree Report) – Equities researchers at Atb Cap Markets decreased their FY2025 EPS estimates for Organigram in a research report issued to clients and investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.13) for the year, down from their prior estimate of ($0.12). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share.

OGI has been the subject of a number of other reports. ATB Capital reduced their price target on shares of Organigram from C$5.25 to C$3.50 in a research report on Tuesday. Canaccord Genuity Group reduced their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research report on Monday, December 9th.

Check Out Our Latest Research Report on Organigram

Organigram Stock Performance

Organigram stock opened at C$2.09 on Thursday. Organigram has a 1-year low of C$1.61 and a 1-year high of C$3.95. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The firm has a market capitalization of C$226.91 million, a PE ratio of -0.83, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. The firm’s 50 day simple moving average is C$2.26 and its 200 day simple moving average is C$2.30.

Insiders Place Their Bets

In other Organigram news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28. Corporate insiders own 31.32% of the company’s stock.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Featured Stories

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.